Cover Image

CCN5 activation by free or encapsulated EGCG is required to render triple‐negative breast cancer cell viability and tumor progression

Abstract Epigallocatechin‐3‐gallate (EGCG) has been considered an anticancer agent despite conflicting and discrepant bioavailability views. EGCG impairs the viability and self‐renewal capacity of triple‐negative breast cancer (TNBC) cells and makes them sensitive to estrogen via activating ER‐α. Su...

Full description

Saved in:
Bibliographic Details
Main Authors: Amlan Das (Author), Inamul Haque (Author), Priyanka Ray (Author), Arnab Ghosh (Author), Debasmita Dutta (Author), Mohiuddin Quadir (Author), Archana De (Author), Sumedha Gunewardena (Author), Indranil Chatterjee (Author), Snigdha Banerjee (Author), Scott Weir (Author), Sushanta K. Banerjee (Author)
Format: Book
Published: Wiley, 2021-04-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items